The current status of HCV, HIV, HBV NAT screening Ewa Brojer Institute of Hematology and Blood Transfusion, Warsaw, Poland - PowerPoint PPT Presentation

1 / 12
About This Presentation
Title:

The current status of HCV, HIV, HBV NAT screening Ewa Brojer Institute of Hematology and Blood Transfusion, Warsaw, Poland

Description:

The current status of HCV, HIV, HBV NAT screening Ewa Brojer Institute of Hematology and Blood Transfusion, Warsaw, Poland Serology - anti-HCV. anti-HIV, HBsAg – PowerPoint PPT presentation

Number of Views:202
Avg rating:3.0/5.0
Slides: 13
Provided by: EwaBr7
Learn more at: https://www.nibsc.org
Category:

less

Transcript and Presenter's Notes

Title: The current status of HCV, HIV, HBV NAT screening Ewa Brojer Institute of Hematology and Blood Transfusion, Warsaw, Poland


1
The current status of HCV, HIV, HBV NAT
screening Ewa Brojer Institute of Hematology
and Blood Transfusion, Warsaw, Poland
  • Serology - anti-HCV. anti-HIV, HBsAg
  • NAT - HCV RNA - since 2000
  • HIV RNA
  • HBV DNA
  • no anti-HBc

38.5 mln - population 1mln donations/year
since 2005
2
HCV NAT results (March 2000 - Dec 2004)
3
High frequency of HCV window period donors in
Poland (2000-2004)
4
Study of HCV window period donors
  • anti-HCV seroconversion in all donors
  • introduction of epidemiological questionaire to
    identify the source and date of infection
  • look back studies of all repeat donors

5
HCV RNA detection in look back samples of HCV
RNA positive/anti-HCV negative repeat blood
donors
6
Since 2005 - HBV, HCV and HIV NAT
  • Cobas Ampliscreen (Roche)
  • 24 donation plasma pools
  • TMA HCV/HIV/HBV (Chiron)
  • single donations
  • Reference Lab IHBT, Warsaw
  • certification for all NAT Laboratories

7
Why HBV DNA testing in pools not larger than 24
donations?
  • Effectivity of plasma pool Cobas Ampliscreen
    testing revealed in preliminary study
  • 2 HBV DNA positives/60 000 dodations tested in
    24 donation pools
  • No preliminary studies with TMA single donation
    testing
  • Higher sensitivity of Cobas Ampliscreen than
    Chiron TMA
  • Lower price in tenders

8
HBV DNA detection in HBsAg negative blood donors
Discrepancies between ULTRIO and HBV
Discrimination
9
Serological and molecular characteristics of HBV
DNA ()/HBsAg(-) donors
with participation of dr Zaaijer, dr Koppelman
and dr Laperche HBsAg pos in PRISM test
Detected by mini-pool testing, single dontion
testing
10
Examples of HBV Ultrio discrepant samples
Nuclisens Extractor (Organon Tecnika)
11
Examples of HBV DNA detection in Ultrio
discrepant samples
Nuclisens Extractor (Organon Technika)
12
Algorithm for HBV DNA detection in HBsAg negative
donors
ULTRIO () HBV Discrimination ()
ULTRIO ( ) Discrimination (-)
Donor is HBV DNA positive
Repeat ULTRIO
(-)
Donor is HBV DNA negative
() Cobas Ampliscreen DNA from 2 ml of plasma by
Nuclisens Extractor
()
(-)
Write a Comment
User Comments (0)
About PowerShow.com